TABLE 3.
Gene amplifiedb | No. of positive PCRs/no. of reactions for individual mice infected with the following virusesc:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Uninf.
|
ΔM83 only
|
ΔM83 + K181
|
||||||||||
Mouse 1 | Mouse 2 | Mouse 1 | Mouse 2 | Mouse 3 | Mouse 4 | Mouse 1 | Mouse 2 | Mouse 3 | Mouse 4 | Mouse 5 | Mouse 6 | |
IE1 | 0/6 | 0/6 | 2/6 | 1/6 | 0/6 | 2/6 | 6/6 | 6/6 | 0/13 | 6/6 | 4/4 | 4/4 |
gpt | 0/4 | 0/4 | 1/4 | 1/4 | 1/4 | 2/4 | 0/4 | 1/4 | 0/4 | 0/4 | 2/4 | 0/4 |
The same BALB/c mice described in Table 2 that were i.p. immunized with 200 PFU of tissue culture-derived ΔM83 were either challenged with K181 (see Table 2) or left unchallenged. Five months after the challenge day, mice were sacrificed, spleens were harvested, splenic stromal fractions were prepared, and genomic DNA was isolated for nested PCR.
The same genomic DNA preparations were used for nested-PCR detection of both MCMV IE1 sequences or gpt sequences from ΔM83.
Virus inoculation groups: Uninf., uninfected; ΔM83 only, ΔM83 immunization only; ΔM83 + K181, ΔM83 immunization and K181 challenge.